Usefulness of C-reactive Protein Testing in Acute Cough
NCT01794819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 179
Last updated 2013-02-20
Summary
The aim of this study is to evaluate the usefulness in Russian general practice of C-reactive protein testing in patients with acute cough or lower respiratory tract infections.
In addition to studying the effect of C-reactive protein testing on the prescription of antibiotics, the purpose is to find out whether the frequency of referral to radiography could be reduced.
Conditions
- Respiratory Tract Infections
Interventions
- DEVICE
-
C-reactive protein test
Results provides within 5 minutes. This test is based on solid-phase sandwich immunometric analysis. The measurement range in whole blood samples is 8-200 mg/L.
Sponsors & Collaborators
-
University of Tromso
collaborator OTHER -
Northern State Medical University
lead OTHER
Principal Investigators
-
Hasse Melbye, PhD · University of Tromsø, Department of Community Medicine
-
Elena A Andreeva, MD, MPH · Northern State Medical University, Family Medicine Department
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2010-04-30
- Completion
- 2010-04-30
Countries
- Russia
Study Locations
More Related Trials
-
CRP and Lung Ultrasound in Respiratory Evaluation
NCT06294899 ·Status: NOT_YET_RECRUITING
-
Respiratory Tract Infections and Prescription Drugs in Children and in Pregnancy
NCT01109589 ·Status: COMPLETED
-
C Reactive Protein (CRP) Intervention to Reduce Inappropriate Antibiotic Prescriptions in the Primary Healthcare Setting
NCT01918579 ·Status: COMPLETED ·Phase: NA
-
CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan
NCT07261969 ·Status: RECRUITING ·Phase: NA
-
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
NCT01907659 ·Status: COMPLETED ·Phase: NA
-
Acute Upper Respiratory Tract Infection - When is Bacteria Involved?
NCT01580137 ·Status: UNKNOWN
-
Pattern and Outcomes of Chest Diseases
NCT06053528 ·Status: UNKNOWN
-
Prediction of Clinical Course in COVID19 Patients
NCT04377685 ·Status: COMPLETED
-
A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19
NCT04864535 ·Status: UNKNOWN
-
Study Evaluating the Impact of Using Triplex Rapid Diagnostic Tests (SARS-CoV-2/Influenza/RSV) on Antibiotic Prescribing
NCT07243249 ·Status: RECRUITING ·Phase: NA
-
Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards
NCT04544072 ·Status: UNKNOWN
-
Effectiveness of Improving Diagnostic and Communication Skills on Antibiotic Prescribing Appropriateness in Acute Cough
NCT03931577 ·Status: UNKNOWN ·Phase: NA
-
Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization
NCT02538770 ·Status: COMPLETED ·Phase: NA
-
Procalcitonin Versus C-reactive Protein to Guide Therapy in Community Acquired Pneumonia
NCT01018199 ·Status: WITHDRAWN ·Phase: NA
-
Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections
NCT04357938 ·Status: COMPLETED
-
Prognosis and Course of COVID-19 Infection in Hospitalised Patients
NCT04752085 ·Status: COMPLETED
-
An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
NCT06070688 ·Status: RECRUITING ·Phase: NA
-
Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection
NCT04728919 ·Status: UNKNOWN
-
Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary Complications
NCT03816059 ·Status: UNKNOWN
-
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia
NCT04334850 ·Status: COMPLETED ·Phase: NA
-
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
NCT04912895 ·Status: COMPLETED ·Phase: NA
-
Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis
NCT00633191 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of Bacterial Expression and Immune Response in the Severity of Pertussis
NCT05897879 ·Status: RECRUITING ·Phase: NA
-
Long-term Effects of COVID-19: a Comparative Cohort Study
NCT05002205 ·Status: UNKNOWN
-
COVID-19 Infection in Patients With Chronic Pulmonary Diseases.
NCT05087199 ·Status: UNKNOWN